| Members |
targetComponentId |
| Patient unsuitable for procedure due to age |
Not suitable for procedure due to age (finding) |
| Patient unsuitable for procedure due to medical condition |
Not suitable for procedure due to disease (finding) |
| Patient unsuitable for procedure due to psychological condition |
Not suitable for procedure due to mental disorder (finding) |
| Patient ventilated |
On artificial ventilation (finding) |
| Patient withdrawn from trial |
Withdrawn from clinical trial |
| Patient withdrawn from trial |
Withdrawn from clinical trial |
| Patient written birth plan |
Patient written birth plan (record artifact) |
| Patient-initiated diet NOS |
Patient-initiated diet |
| Patient-initiated diet NOS |
Patient-initiated diet |
| Patient-initiated encounter NOS |
Patient encounter status (finding) |
| Patient-initiated encounter NOS |
Patient-initiated encounter (procedure) |
| Pattee operation on auditory canal |
Reconstruction of external auditory canal |
| Patulous umbilicus |
Distension of abdomen |
| Pauciarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Pauciarticular onset juvenile chronic arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Peaceful environment |
Peaceful environment (finding) |
| Peach - dietary |
Peach (substance) |
| Peanut - dietary |
Peanut (substance) |
| Pear - dietary |
Pear (substance) |
| Pectobacterium chrysanthemi |
Dickeya chrysanthemi (organism) |
| Pectoralis major myocutaneous flap plus rib |
Pectoralis major osteomyocutaneous flap of rib |
| Pediatric food panel mix radioallergosorbent test |
Food mix specific IgE antibody measurement |
| Pedicle flap reconstruction - action |
Flap reconstruction - action |
| Pedicle transverse rectus abdominus flap |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
| Pediculus humanus humanus |
Pediculus humanus |
| Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
| Peeling - action |
Stripping - action |
| Pegaptanib 0.3mg intravitreal injection solution 1mL prefilled syringe |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
| Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
| Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
| Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
| Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
| Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
| Pegvisomant 30mg powder for injection solution vial |
Pegvisomant 20 mg powder for solution for injection vial |
| Pelvic contrast radiography |
Plain X-ray of pelvis with contrast (procedure) |
| Pelvic contrast radiography |
Plain X-ray of pelvis with contrast (procedure) |
| Pelvic exenteration, female |
Pelvic exenteration |
| Pelvic floor repair |
Repair of vaginal enterocele |
| Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
| Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
| Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
| Pelvic lymphangiography, bilateral |
Fluoroscopic lymphangiography of bilateral pelvis with contrast (procedure) |
| Pelvic soft tissue X-ray |
Plain X-ray of soft tissue of pelvis (procedure) |
| Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium with antenatal problem |
Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium (disorder) |
| Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium with postnatal complication |
Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium (disorder) |
| Pelvic somatic dysfunction |
Somatic dysfunction |
| Pelvis X-ray |
Plain X-ray of pelvis (procedure) |
| Penetrating injury caused by glass |
Penetrating injury caused by glass fragment |
| Penetrating injury due to glass |
Penetrating injury caused by glass fragment |
| Penetrating wound of orbit without mention of foreign body |
Penetrating wound of orbit |
| Penetrating wound of orbit without mention of foreign body |
Penetrating wound of orbit |
| Penicillin G benzathine 300,000unit/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin antibacterial overdose |
Penicillin overdose |
| Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial |
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection suspension 10mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection suspension 1mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 600,000unt/mL injection suspension 1mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 20mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 2mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 4mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial |
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection |
| Penicillin g procaine 600,000unt/mL injection suspension 1mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g procaine 600,000unt/mL injection suspension 4mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin poisoning NOS |
Poisoning caused by penicillin (disorder) |
| Penicillin v potassium 500mg |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Penicillin v potassium 500mg tablet |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Penicillium mycetogenum |
Penicillium mycetomagenum |
| Penicillium patulum |
Penicillium griseofulvum |
| Penicillium rubrum |
Talaromyces purpureogenus (organism) |
| Penicillium rubrum toxicosis |
Penicillium purpurogenum toxicosis (disorder) |
| Penicilloyl G extract |
Product containing benzylpenicillin (medicinal product) |
| Penicilloyl V extract |
Phenoxymethylpenicillin-containing product |
| Penile disorders NOS |
Disorder of penis |
| Penile disorders NOS |
Disorder of penis |
| Pentamidine isethionate 300mg injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
| Pentamidine isethionate 300mg/5mL nebulizer solution |
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Pentamidine isethionate 300mg/vial injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
| Pentasa 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
| Pentastarch 10% infusion solution bottle |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10% injection solution bag |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL conventional release solution for infusion 500mL bag |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL injection |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL intravenous solution 500mL bag |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 6% in sodium chloride 7.2% conventional release solution for injection |
Product containing only pentastarch (medicinal product) |
| Pentastarch 6% in sodium chloride 7.2% intravenous infusion |
Product containing only pentastarch (medicinal product) |
| Pentastarch 6% infusion solution bottle |
Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Pentastarch allergy |
Non-allergic hypersensitivity to pentastarch |
| Pentobarbital sodium 18.2mg/5ml elixir |
Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Pentobarbital sodium 20mg/5ml elixir |
Pentobarbital sodium 4 mg/mL oral solution |
| Pentose shunt pathway |
Pentose shunt pathway |
| Pentostatin 10mg injection |
Pentostatin 10 mg powder for solution for injection vial |
| Pentosyltransferase |
Pentosyltransferase |
FHIR